The capital raising was mentioned by the last CEO and was explicitly for the cost of entry into the US market.
This is not going to happen until the last quarter of 2007 now, because of the necessity of carrying out trials for the FDA.
The Company has about 10 mill cash reserves, which will keep them going for about 6 months anyway and that is not taking into consideration the increase in sales revenue that is sure to happen in the next 12 months.
horror story, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
